Inosine

From Wikipedia, the free encyclopedia


Inosine
Systematic (IUPAC) name
Inosine
Identifiers
CAS number	58-63-9
ATC code	D06 BB05
PubChem	6021
DrugBank	EXPT02378
Chemical data
Formula	C₁₀H₁₂N₄O₅
Mol. weight	268.229 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Inosine is a molecule (known as a nucleoside) that is formed when hypoxanthine is attached to a ribose ring (also known as a ribofuranose) via a β-N₉-glycosidic bond.

This is a very common modified nucleoside found in tRNAs and is essential for proper translation of the genetic code in Wobble base pairs.

Inosine is a nucleic acid important for RNA editing. A (Adenine) is converted to I (Inosine), which pairs with G (Guanine).

Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements.

It was tried in the seventies in eastern countries for improving athletic performance, based in the fact that is an intermediate compound used in the muscle movements. Nevertheless the clinical trials with this purpose showed no improvement. ^{[citation needed]}

Nowadays, it has been shown that inosine has neuroprotective properties. It has been proposed for administration after stroke, because observation has shown that axonal re-wiring is encouraged.[1]- It has been tried also for multiple sclerosis and is currently in phase II of the trials [2].

It produces uric acid after ingestion, which is a natural antioxidant and a peroxinitrite scavenger, which can explain the behaviour in multiple sclerosis [3](peroxynitrite has been correlated with the axons degeneration [4]).

Currently Boston Life Sciences holds the patent for treatment of stroke [5] and this company is currently investigating its properties for MS under the name axosine for Multiple Sclerosis.

[edit] See also

PDR health study

This biochemistry article is a stub. You can help Wikipedia by expanding it.

Antivirals (primarily J05A, also S01AD and D06BB) edit

Anti-herpesvirus agents		Aciclovir, Cidofovir, Docosanol, Famciclovir, Fomivirsen, Foscarnet, Ganciclovir, Idoxuridine, Penciclovir, Trifluridine, Tromantadine, Valaciclovir, Valganciclovir, Vidarabine
Anti-influenza agents		Amantadine, Oseltamivir, Peramivir, Rimantadine, Zanamivir

Antiretroviral drugs	NRTIs	Abacavir, Didanosine, Emtricitabine, Lamivudine, Stavudine, Zalcitabine, Zidovudine
	NtRTIs	Tenofovir
	NNRTIs	Efavirenz, Delavirdine, Nevirapine
	PIs	Amprenavir, Atazanavir, Darunavir, Fosamprenavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Tipranavir
	Fusion inhibitors	Enfuvirtide

Other antiviral agents		Adefovir, Fomivirsen, Imiquimod, Inosine,Interferon, Podophyllotoxin, Ribavirin, Viramidine